Lysosomal cysteine peptidases and malignant tumors

Advances in Experimental Medicine and Biology

Volumn 421, Issue , 1997, Pages 253-257

  Kirschke, Heidrun ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; CYSTEINE PROTEINASE; LYSOSOME ENZYME;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL TRANSFORMATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYSOSOME; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 0030848054     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9613-1_33     Document Type: Article

References (28)

1. Kane, S.E., and Gottesman, M.M., 1990, The role of cathepsin L in malignant transformation, Semin. Cancer Biol. 1: 127-136.
2. Sloane, B.F., Moin, K., Krepela, E., and Rozhin, J., 1990, Cathepsin B and its endogenous inhibitors: the role in tumor malignancy, Cancer Metast. Rev. 9: 333-352.
3. Gottesman, M.M., 1993, Cathepsin L and cancer, in: Proteolysis and Protein Turnover, Bond, J.S., and Barrett, A.J., eds., Portland Press, London and Chapel Hill, 247-251.
4. Berquin, I.M., and Sloane, B.F., 1996, Cathepsin B expression in human tumors, in: Intracellular Protein Catabolism, Suzuki, K., and Bond, J.S., eds., Plenum Press, New York and London, 281-294.
5. Kirschke, H., Barrett, A.J., and Rawlings, N.D., 1995, Proteinases 1: Lysosomal cysteine proteinases, Protein Profile 2: 1587-1643.
6. Schmitt, M., Goretzki, L., Jänicke, F., Calvete, J., Eulitz, M., Kobayashi, H., Chucholowski, N., and Graeff, H., 1991, Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer, Biomed. Biochim. Acta 50: 731-741.
7. McCoy, K., Gal, S., Schwartz, R.H., and Gottesman, M.M., 1988, An acid protease secreted by transformed cells interferes with antigen processing, J. Cell Biol. 106: 1879-1884.
8. Kasai, M., Shirasawa, T., Kitamura, M., Ishido, K., Kominami, E., and Hi- rokawa, K., 1993, Proenzyme form of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody, Cell Immunol. 150: 124-136.
9. Weber, E., Günther, D., Laube, F., Wiederanders, B., and Kirschke, H., 1994, Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth. J. Cancer Res. Clin. Oncol. 120: 564-567.
10. Homma, K., Kurata, S., and Natori, S., 1994, Purification, characterization, and cDNA cloning of procathepsin L from the culture medium of NIH-Sape- 4, an embryonic cell line of Sarcophaga peregrina (flesh fly), and its involvement in the differentiation of imaginal discs, J. Biol. Chem. 269: 15258-15264.
11. Dehrmann, F.M., Coetzer, T.H.T., Pike, R.N., and Dennison, C., 1995, Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium, Arch. Biochem. Biophys. 324: 93-98.
12. Turk, B., Dolenc, I., Turk, V., and Bieth, J.G., 1993, Kinetics of the pH-induced inactivation of human cathepsin L, Biochemistry 32: 375-380.
13. Brix, K., Lemansky, P., and Herzog, V., 1996. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 137: 1963-1974.
14. Rozhin, J., Sameni, M., Ziegler, G., and Sloane, B.F., 1994, Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54 6517-6525.
15. Ebert, W., Werle, B., Ebert, E., Kos, J., Lah, T., and Abrahamson, M., 1996, Cathepsins and cystatins: prognostic factors in human lung cancer, 11th International Conference on Proteolysis and Protein Turnover: Turku (Poster Abstract No 132).
16. Scaddan, P.B., and Dufresne, M.J., 1993. Characterization of cysteine pro teases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells, Invas. Metast. 13: 301-313
17. Sheahan, K., Shuja, S., and Murnane, M.J., 1989, Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res. 49: 3809-3814.
18. Adenis, A., Huet, G., Zerimech, F., Hecquet, B., Balduyck, M., and Peyrat, J.P., 1995, Cathepsin B. L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett. 96: 267-275.
19. Rozhin, J., Wade, R.L., Honn, K.V., and Sloane, B.F., 1989, Membrane-as- sociated cathepsin L: a role in metastasis of melanomas, Biochem. Biophys. Res. Commun. 164: 556-561.
20. Qian, F., Bajkowski, A.S., Steiner, D.F., Chan, S.J., and Frankfater, A., 1989. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues, Cancer Res. 49: 4870-4875.
21. Kageshita, T., Yoshii, A., Kimura, T., Maruo, K., Ono, T., Himeno, M., and Nishimura, Y., 1995, Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours, Arch. Dermatol. Res. 287: 266-272.
22. Sivaparvathi, M., Yamamoto, M., Nicolson, G.L., Gokaslan, Z.L., Fuller, G.N., Liotta, L.A., Sawaya, R., and Rao, J.S., 1996, Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas, Clin. Exp. Metast. 14: 27-34.
23. Denhardt, D.T., Greenberg, A.H., Egan, S.E., Hamilton, R.T., and Wright, J.A., 1987, Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 2: 55-59.
24. Chambers, A.F., Colella, R., Denhardt, D.T., and Wilson, S.M., 1992, In-creased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells, Mol. Carcinog. 5: 238-245.
25. Sivaparvathi, M., Sawaya, R., Gokaslan, Z.L., Chintala, K.S., and Rao, J.S., 1996, Expression and the role of cathepsin H in human glioma progression and invasion, Cancer Lett. 104: 121-126.
26. Gabrijelčič, D., Svetic, B., Spaić, D., Škrk, J., Budihna, M., Dolenc, I., Po povič, T., Cotič, V., and Turk, V, 1992, Cathepsins B, H and L in human breast carcinoma, Eur. J. Clin. Chem. Clin. Biochem. 30: 69-74.
27. Murnane, M.J., Cai, J., Shuja, S., Coté, L., Del Re, E., Iacobuzio-Donahue, C., Kim, K., and Sheahan, K., 1995, Changing patterns of proteolytic expression with colorectal tumor progression, in: Proteases Involved in Cancer, Suzuki, M., and Hiwasa, T., eds., Monduzzi Editore, Bologna, 11-26.
28. Yagel, S., Warner, A.M., Nellans, H.N., Lala, P.K., Waghorne, C., and Denhardt, D.T., 1989, Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res. 49: 3553-3557.